Statin drug: New cancer alert

A new drugs alert has gone out this week, warning heart patients that a statin drug for lowering cholesterol may cause cancer.

America’s drug regulator, the Food and Drug Administration (FDA), issued the warning yesterday (September 10) after reviewing the findings of a study into Vytorin, a combination of the two statin drugs simvastatin and ezetimibe. 

The researchers have found that many more Vytorin patients developed different cancers, including skin cancer, than those given a placebo, during the five years of the trial.

The FDA points out that the cancer risk has been discovered only in a trial known as SEAS (Simvastatin and Ezetimibe in Aortic Stenosis), while other trials into Vytorin haven’t found any risk.

(Source:  FDA website).

Related WDDTY Content

Cholesterol lowering - The statin 'wonder' drugs

Statins are the new wonder drugs now used to prevent everything from heart disease to Alzheimer's. But new evidence from a Finnish doctor shows that s...

Cyclosporin raises skin cancer risk in psoriasis patients

Psoriasis treatment that includes the immunosuppressant cyclosporin along with psoralen and ultraviolet A (PUVA) light therapy is associated with a si...

Statin: Regulators extend licence, even though it doesn’t help heart patients

On the very day when AstraZeneca’s cholesterol-lowering statin drug Crestor (rosuvastatin calcium) was approved to treat atherosclerosis (hardening of...

Cholesterol lowering: - Diet is as good as a statin

Your cholesterol levels are a little on the high side. Almost without thinking, your doctor reaches for his pad to write a prescription for a statin...

Statins: They do increase prostate cancer risk if you’re overweight

Cholesterol-lowering statin drugs increase the risk of prostate cancer in overweight men, a new study has discovered.

Use of sunlamps may double skin cancer risk

People who use sunlamps to achieve an all-year tan may double their risk of developing skin cancer, according to a new US study.